159 related articles for article (PubMed ID: 27167413)
1. A 9-month, randomized, assessor-blinded, parallel-group study to evaluate clinical effects of film-forming medical devices containing photolyase and sun filters in the treatment of field cancerization compared with sunscreen in patients after successful photodynamic therapy for actinic keratosis.
Eibenschutz L; Silipo V; De Simone P; Buccini PL; Ferrari A; Carbone A; Catricalà C
Br J Dermatol; 2016 Dec; 175(6):1391-1393. PubMed ID: 27167413
[No Abstract] [Full Text] [Related]
2. Efficacy of different photoprotection strategies in preventing actinic keratosis new lesions after photodynamic therapy. The ATHENA study: a two-center, randomized, prospective, assessor-blinded pragmatic trial.
Pavone PS; Lovati S; Scarcella G; Milani M
Curr Med Res Opin; 2019 Jan; 35(1):141-145. PubMed ID: 30404544
[No Abstract] [Full Text] [Related]
3. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial.
Puviani M; Galloni C; Marchetti S; Sergio Pavone P; Lovati S; Pistone G; Caputo V; Tilotta G; Scarcella G; Campione E; Diluvio L; Garofalo V; Bianchi L; Milani M
Curr Med Res Opin; 2017 Jul; 33(7):1255-1259. PubMed ID: 28358282
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.
Puviani M; Barcella A; Milani M
G Ital Dermatol Venereol; 2013 Dec; 148(6):693-8. PubMed ID: 24442053
[TBL] [Abstract][Full Text] [Related]
5. Management of cancerization field with a medical device containing photolyase: a randomized, double-blind, parallel-group pilot study.
Moscarella E; Argenziano G; Longo C; Aladren S
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e401-e403. PubMed ID: 28294419
[No Abstract] [Full Text] [Related]
6. Comparative Effects of Sunscreens Alone vs Sunscreens Plus DNA Repair Enzymes in Patients With Actinic Keratosis: Clinical and Molecular Findings from a 6-Month, Randomized, Clinical Study.
Carducci M; Pavone PS; De Marco G; Lovati S; Altabas V; Altabas K; Emanuele E
J Drugs Dermatol; 2015 Sep; 14(9):986-90. PubMed ID: 26355618
[TBL] [Abstract][Full Text] [Related]
7. The use of a sunscreen containing DNA-photolyase in the treatment of patients with field cancerization and multiple actinic keratoses: a case-series.
Navarrete-Dechent C; Molgó M
Dermatol Online J; 2017 Jan; 23(1):. PubMed ID: 28329483
[TBL] [Abstract][Full Text] [Related]
8. A Novel Technology: Sunscreen With Actinic Damage Repair.
Kircik Md LH
J Drugs Dermatol; 2017 May; 16(5):s59-s60. PubMed ID: 28628692
[No Abstract] [Full Text] [Related]
9. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial.
Agozzino M; Russo T; Franceschini C; Mazzilli S; Garofalo V; Campione E; Bianchi L; Milani M; Argenziano G
Curr Med Res Opin; 2019 Oct; 35(10):1785-1792. PubMed ID: 31148490
[No Abstract] [Full Text] [Related]
10. Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis.
Gilaberte Y; Aguilar M; Almagro M; Correia O; Guillén C; Harto A; Pérez-García B; Pérez-Pérez L; Redondo P; Sánchez-Carpintero I; Serra-Guillén C; Valladares LM
Actas Dermosifiliogr; 2015 Oct; 106(8):623-31. PubMed ID: 26115793
[TBL] [Abstract][Full Text] [Related]
11. Hexyl-5-aminolaevulinate 0·2% vs. methyl-5-aminolaevulinate 16% daylight photodynamic therapy for treatment of actinic keratoses: results of a randomized double-blinded pilot trial.
Neittaanmäki-Perttu N; Grönroos M; Karppinen TT; Tani TT; Snellman E
Br J Dermatol; 2016 Feb; 174(2):427-9. PubMed ID: 26011755
[No Abstract] [Full Text] [Related]
12. Fluorescent photodiagnostic evaluation of field cancerization treated with a medical device containing piroxicam 0.8% and sunscreen SPF 50+ for actinic keratosis.
Bobyr I; Campanati A; Giacchetti A; Offidani A
Photodermatol Photoimmunol Photomed; 2019 Jul; 35(4):277-279. PubMed ID: 30690758
[No Abstract] [Full Text] [Related]
13. Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy.
Szeimies RM; Torezan L; Niwa A; Valente N; Unger P; Kohl E; Schreml S; Babilas P; Karrer S; Festa-Neto C
Br J Dermatol; 2012 Jul; 167(1):150-9. PubMed ID: 22329784
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial.
Alvares BA; Miola AC; Schimitt JV; Miot HA; Abbade LPF
An Bras Dermatol; 2022; 97(2):157-165. PubMed ID: 35039206
[TBL] [Abstract][Full Text] [Related]
15. Can photodynamic therapy reverse the signs of photoageing and field cancerization?
Morton CA
Br J Dermatol; 2012 Jul; 167(1):2. PubMed ID: 22738409
[No Abstract] [Full Text] [Related]
16. The effects of sunscreen use and window glass on daylight photodynamic therapy dosimetry.
O'Mahoney P; Khazova M; Ibbotson S; Eadie E
Br J Dermatol; 2019 Jul; 181(1):220-221. PubMed ID: 30891731
[No Abstract] [Full Text] [Related]
17. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy simplified: nonprepared, moderate-grade actinic keratosis lesions respond equally well to 5-aminolaevulinic acid patch photodynamic therapy as do mild lesions.
Szeimies RM; Hauschild A; Ortland C; Moor AC; Stocker M; Surber C
Br J Dermatol; 2015 Nov; 173(5):1277-9. PubMed ID: 25940103
[No Abstract] [Full Text] [Related]
19. Simulated-daylight photodynamic therapy with BF-200 aminolaevulinic acid for actinic keratosis: assessment of the efficacy and tolerability in a retrospective study.
Kellner C; Bauriedl S; Hollstein S; Reinhold U
Br J Dermatol; 2015 Apr; 172(4):1146-8. PubMed ID: 25244353
[No Abstract] [Full Text] [Related]
20. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]